Cargando…
Emerging diabetes therapies: Bringing back the β-cells
BACKGROUND: Stem cell therapies are finally coming of age as a viable alternative to pancreatic islet transplantation for the treatment of insulin-dependent diabetes. Several clinical trials using human embryonic stem cell (hESC)-derived β-like cells are currently underway, with encouraging prelimin...
Autores principales: | Basile, G., Qadir, M.M.F., Mauvais-Jarvis, F., Vetere, A., Shoba, V., Modell, A.E., Pastori, R.L., Russ, H.A., Wagner, B.K., Dominguez-Bendala, J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987999/ https://www.ncbi.nlm.nih.gov/pubmed/35331962 http://dx.doi.org/10.1016/j.molmet.2022.101477 |
Ejemplares similares
-
MicroRNA-7 Control of β-Cell Replication
por: Domínguez-Bendala, Juan, et al.
Publicado: (2013) -
The Role of MicroRNAs in Diabetes-Related Oxidative Stress
por: Qadir, Mirza Muhammad Fahd, et al.
Publicado: (2019) -
Bringing Production Back into Development: An introduction
por: Chang, Ha-Joon, et al.
Publicado: (2021) -
Bringing the state back in /
Publicado: (1985) -
Bringing dead proteins back to life
por: A Wustman, Brandon, et al.
Publicado: (2014)